| |
Notes |
|
2025
R'000 |
| Reconciliation of operating profit to cash generated by operations: |
|
|
|
| Operating (loss)/profit |
|
(5 225 999) |
|
| Adjustments for: |
|
|
|
| Depreciation of property, plant and equipment |
4.3 |
72 564 |
|
| Depreciation on leased assets |
4.4 |
56 039 |
|
| Amortisation of intangible assets |
4.2 |
286 217 |
|
| Fair value gain on financial instruments |
3.5 |
(242 637) |
|
| Fair value loss on financial instruments |
3.5 |
21 896 |
|
| Fair value gain on surety receivable |
3.5 |
(2 200) |
|
| Gain on effective settlement of pre-existing relationships upon obtaining control of Cell C |
2.2.1 |
(480 707) |
|
| Impairment of intangible assets |
4.2 |
144 381 |
|
| Impairment of property, plant and equipment |
4.3 |
14 248 |
|
| Impairment reversal of loans |
|
(10 103) |
|
| Impairment of inventory |
|
17 424 |
|
| Impairment of goodwill |
4.1 |
200 592 |
|
| Loan forgiveness |
|
(719) |
|
| Loss on disposal of property, plant and equipment |
|
3 163 |
|
| Loss on disposal of intangible assets |
|
37 092 |
|
| Loss on disposal of subsidiaries |
1.3 |
6 132 514 |
|
| Net (profit)/loss on disposal of investment in joint ventures |
|
(1 094) |
|
| Termination of lease |
|
(144) |
|
| Lease modification income |
3.6 |
(326 303) |
|
| Lease incentive received |
|
(10 401) |
|
| (Gain)/loss on modification/derecognition of financial instruments |
1.3 |
(192 662) |
|
| Loss on initial recognition of financial liability |
3.5 |
281 117 |
|
| Equity compensation benefit expense |
5.2 |
32 913 |
|
| Changes in working capital: |
|
|
|
| Increase in inventories |
|
(698 529) |
|
| Increase in trade and other receivables |
|
(215 834) |
|
| Increase in trade and other payables |
|
771 189 |
|
| Increase in advances to customers |
|
(239 562) |
|
| |
|
424 455 |
|
